Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis

BACKGROUND: Recent clinical studies show that tyrosine kinase inhibitors slow the rate of lung function decline and decrease the number of acute exacerbations in patients with Idiopathic Pulmonary Fibrosis (IPF). However, in the murine bleomycin model of fibrosis, not all tyrosine kinase signaling i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Respir Res
Autors principals: MacKenzie, BreAnne, Korfei, Martina, Henneke, Ingrid, Sibinska, Zaneta, Tian, Xia, Hezel, Stefanie, Dilai, Salma, Wasnick, Roxana, Schneider, Beate, Wilhelm, Jochen, El Agha, Elie, Klepetko, Walter, Seeger, Werner, Schermuly, Ralph, Günther, Andreas, Bellusci, Saverio
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495640/
https://ncbi.nlm.nih.gov/pubmed/26138239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0242-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars